The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, D.
Right arrow Articles by McMahon, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, D.
Right arrow Articles by McMahon, M.
The Journal of Immunology, 1999, 163: 5796-5805.
Copyright © 1999 by The American Association of Immunologists

Sustained Activation of the Raf-MEK-ERK Pathway Elicits Cytokine Unresponsiveness in T Cells1

Dan Chen2,*, Victoria Heath{dagger}, Anne O’Garra{dagger}, James Johnston* and Martin McMahon3,*

Departments of * Cell Signaling and {dagger} Immunobiology, DNAX Research Institute, Palo Alto, CA 94304

Activation of T cells via the TCR and other costimulatory receptors triggers a number of signaling cascades. Among them, the Ras-activated Raf-mitogen-activated protein/extracellular signal-related kinase (ERK) kinase (MEK)-ERK signaling cascade has been demonstrated to be crucial for both T cell development and activation. It has previously been demonstrated that high doses of Ag or anti-CD3 mAb are able to induce in T cells a nonresponsive state to subsequent treatment with cytokines such as IL-2. The precise biochemical mechanisms underlying this effect are not fully characterized. In this study, we demonstrate that cytokine nonresponsiveness is accompanied by the induction of the cyclin-dependent kinase inhibitor p21Cip1 that is mediated, at least in part, by the activation of the Raf-MEK-ERK pathway. Furthermore, we demonstrate that selective activation of the Raf-MEK-ERK signaling pathway in T cells is sufficient to induce cytokine nonresponsiveness in both a T cell clone and naive primary T cells. In this case, nonresponsiveness is accompanied by the induction of p21Cip1 and the prevention of p27Kip1 down-regulation, leading to inhibition of cyclin E/cyclin-dependent kinase 2 activity. These data suggest that anti-CD3 mAb-induced cytokine nonresponsiveness may be a consequence of hyperactivation of the Raf-MEK-ERK pathway, leading to alterations in the expression of key cell cycle regulators. These observations may provide a novel insight into the mechanisms of induction of peripheral tolerance.




This article has been cited by other articles:


Home page
J. Immunol.Home page
E. C. Jury, D. A. Isenberg, C. Mauri, and M. R. Ehrenstein
Atorvastatin Restores Lck Expression and Lipid Raft-Associated Signaling in T Cells from Patients with Systemic Lupus Erythematosus
J. Immunol., November 15, 2006; 177(10): 7416 - 7422.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. K. Khanna, M. Plummer, V. Nilakantan, and G. M. Pieper
Recombinant p21 Protein Inhibits Lymphocyte Proliferation and Transcription Factors
J. Immunol., June 15, 2005; 174(12): 7610 - 7617.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Waiczies, T. Prozorovski, C. Infante-Duarte, A. Hahner, O. Aktas, O. Ullrich, and F. Zipp
Atorvastatin Induces T Cell Anergy via Phosphorylation of ERK1
J. Immunol., May 1, 2005; 174(9): 5630 - 5635.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. L. Adams, A. M. Grierson, A. M. Mowat, M. M. Harnett, and P. Garside
Differences in the Kinetics, Amplitude, and Localization of ERK Activation in Anergy and Priming Revealed at the Level of Individual Primary T Cells by Laser Scanning Cytometry
J. Immunol., August 1, 2004; 173(3): 1579 - 1586.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L. L. Molinero, M. B. Fuertes, L. Fainboim, G. A. Rabinovich, and N. W. Zwirner
Up-regulated expression of MICA on activated T lymphocytes involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase, and calcineurin
J. Leukoc. Biol., June 1, 2003; 73(6): 815 - 822.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Asai, S. Hachimura, M. Kimura, T. Toraya, M. Yamashita, T. Nakayama, and S. Kaminogawa
T Cell Hyporesponsiveness Induced by Oral Administration of Ovalbumin Is Associated with Impaired NFAT Nuclear Translocation and p27kip1 Degradation
J. Immunol., November 1, 2002; 169(9): 4723 - 4731.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Moelling, K. Schad, M. Bosse, S. Zimmermann, and M. Schweneker
Regulation of Raf-Akt Cross-talk
J. Biol. Chem., August 16, 2002; 277(34): 31099 - 31106.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
P. E. Hughes, B. Oertli, M. Hansen, F.-L. Chou, B. M. Willumsen, and M. H. Ginsberg
Suppression of Integrin Activation by Activated Ras or Raf Does Not Correlate with Bulk Activation of ERK MAP Kinase
Mol. Biol. Cell, July 1, 2002; 13(7): 2256 - 2265.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Graness, C. E. Chwieralski, D. Reinhold, L. Thim, and W. Hoffmann
Protein Kinase C and ERK Activation Are Required for TFF- peptide-stimulated Bronchial Epithelial Cell Migration and Tumor Necrosis Factor-alpha -induced Interleukin-6 (IL-6) and IL-8 Secretion
J. Biol. Chem., May 17, 2002; 277(21): 18440 - 18446.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. B. Gauld, D. Blair, C. A. Moss, S. D. Reid, and M. M. Harnett
Differential Roles for Extracellularly Regulated Kinase-Mitogen-Activated Protein Kinase in B Cell Antigen Receptor-Induced Apoptosis and CD40-Mediated Rescue of WEHI-231 Immature B Cells
J. Immunol., April 15, 2002; 168(8): 3855 - 3864.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Jackson, A. DeLoose, and K. M. Gilbert
Induction of Anergy in Th1 Cells Associated with Increased Levels of Cyclin-Dependent Kinase Inhibitors p21Cip1 and p27Kip1 1
J. Immunol., January 15, 2001; 166(2): 952 - 958.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. H. Hansen, M. M. P. Zegers, M. Woodrow, P. Rodriguez-Viciana, P. Chardin, K. E. Mostov, and M. McMahon
Induced Expression of Rnd3 Is Associated with Transformation of Polarized Epithelial Cells by the Raf-MEK-Extracellular Signal-Regulated Kinase Pathway
Mol. Cell. Biol., December 15, 2000; 20(24): 9364 - 9375.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
J. F. Modiano, J. Mayor, C. Ball, M. K. Fuentes, and D. S. Linthicum
CDK4 Expression and Activity Are Required for Cytokine Responsiveness in T Cells
J. Immunol., December 15, 2000; 165(12): 6693 - 6702.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. Zhu, H. Huang, L. Guo, T. Stonehouse, C. J. Watson, J. Hu-Li, and W. E. Paul
Transient Inhibition of Interleukin 4 Signaling by T Cell Receptor Ligation
J. Exp. Med., October 9, 2000; 192(8): 1125 - 1134.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. B. Carter and G. W. Hunninghake
A Constitutive Active MEK right-arrow ERK Pathway Negatively Regulates NF-kappa B-dependent Gene Expression by Modulating TATA-binding Protein Phosphorylation
J. Biol. Chem., September 1, 2000; 275(36): 27858 - 27864.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.